Answers are grounded in this paper and cite their sources.
The activation ligand and the molecular and cellular requirements for accessory cell function in murine T cell activation initiated by rabbit anti-Thy-1 antibodies were examined. Both rabbit anti-mouse brain (RaMB) and anti-Thy-1 glycoprotein antibodies initiated T lymphocyte proliferation and precipitated a unique 25,000-dalton glycoprotein after absorption with S49 Thy-1− but not with S49 Thy-1+ T lymphoma cell lines, suggesting that the Thy-1 glycoprotein shares at least a portion of the activation determinant. Antibodies directed against the allodeterminants (Thy-1.1, 1.2) were neither mitogenic or inhibitory to rabbit anti-Thy-1-induced responses. Since rat Thy-1-bearing tissue was effective in absorbing mitogenic activity, it was concluded that the activation ligand was composed of at least 1 rat-mouse shared determinant and possibly an additional mouse-specific determinant(s). The accessory cell requirement was examined by comparing the ability of a number of cell populations to provide helper activity when added to cultures of purified lymph node T lymphocytes pretreated with RaMB. With the exception of peritoneal macrophages, a variety of Fc receptor-(FcR) positive cell types supplied accessory cell function, including B cells, T cells, and macrophages. Helper cell effects were abrogated by UV or glutaralde-hyde treatment, suggesting a requirement for membrane mobility. Accessory cells were not required if aggregation of the RaMB-Thy-1 complex was initiated by anti-lg cross-linking in the absence of helper cells. The hypothesis that the co-redistribution of the FcR-anti-Thy-1 complex involves other membrane proteins in the plasma membrane was tested using monoclonal antibodies directed against H-2, la, and T200 glycoproteins. Anti-H-2K and anti-H-2D, anti-T200, and anti-la antibodies inhibited activation of spleen cells by RaMB but did not affect Con A-, PHA-, or LPS-induced proliferative responses. Antibody pretreatment and genetic evidence strongly favored the conclusion that inhibition by anti-H-2 and anti-T200 antibodies was directed through the accessory cell rather than the responding T cell. It is postulated that transmembrane mobility of these components and/or the FcR on the accessory cell is in some way compromised by these antibodies.
No takes yet. Share an insight, caveat, or question.
Maino et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: